Mineralys Therapeutics, Inc. MLYS Incentive stock program, shares reserved for future grants (in shares)
Incentive stock program, shares reserved for future grants (in shares) at other companies
Other financials
Where this comes from
Reported directly by Mineralys Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.
The official record: Mineralys Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mineralys Therapeutics, Inc.'s incentive stock program, shares reserved for future grants (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mineralys Therapeutics, Inc.'s incentive stock program, shares reserved for future grants (in shares)?
- Mineralys Therapeutics, Inc. (MLYS) reported incentive stock program, shares reserved for future grants (in shares) of $3.41M in Q1 2026.
- How has Mineralys Therapeutics, Inc.'s incentive stock program, shares reserved for future grants (in shares) changed year-over-year?
- Mineralys Therapeutics, Inc.'s incentive stock program, shares reserved for future grants (in shares) increased by 8.6% year-over-year, from $3.14M to $3.41M.
- What is the long-term trend for Mineralys Therapeutics, Inc.'s incentive stock program, shares reserved for future grants (in shares)?
- Over 2 years (2023 to 2025), Mineralys Therapeutics, Inc.'s incentive stock program, shares reserved for future grants (in shares) has grown at a -20.2% compound annual growth rate (CAGR), from $3.21M to $2.04M.